Loss of Parkinson’s susceptibility gene LRRK2 promotes carcinogen-induced lung tumorigenesis
Abstract Pathological links between neurodegenerative disease and cancer are emerging. LRRK2 overactivity contributes to Parkinson’s disease, whereas our previous analyses of public cancer patient data revealed that decreased LRRK2 expression is associated with lung adenocarcinoma (LUAD). The clinic...
Enregistré dans:
Auteurs principaux: | Chandra Lebovitz, Nicole Wretham, Maryam Osooly, Katy Milne, Tia Dash, Shelby Thornton, Basile Tessier-Cloutier, Paalini Sathiyaseelan, Svetlana Bortnik, Nancy Erro Go, Elizabeth Halvorsen, Rachel A. Cederberg, Norman Chow, Nancy Dos Santos, Kevin L. Bennewith, Brad H. Nelson, Marcel B. Bally, Wan L. Lam, Sharon M. Gorski |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/a628231eefc547ca89a67c8ce3fcdf31 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
LRRK2 kinase activity is dependent on LRRK2 GTP binding capacity but independent of LRRK2 GTP binding.
par: Jean-Marc Taymans, et autres
Publié: (2011) -
Cryo-EM analysis of homodimeric full-length LRRK2 and LRRK1 protein complexes
par: Kushal Sejwal, et autres
Publié: (2017) -
Understanding LRRK2 kinase activity in preclinical models and human subjects through quantitative analysis of LRRK2 and pT73 Rab10
par: Xiang Wang, et autres
Publié: (2021) -
Thirdhand smoke: Genotoxicity and carcinogenic potential
par: Bo Hang, et autres
Publié: (2020) -
LRRK2 levels in immune cells are increased in Parkinson’s disease
par: D. A. Cook, et autres
Publié: (2017)